Search Results - iBoxes

Play Episode

7min

Proactive - Interviews for investors

BluGlass talks quantum sensing & commercial wins

BluGlass Head of Corporate and Investor Relations Stefanie Winwood talked with Proactive at the AIM's Small and Midcap Conference about the company’s work in gallium nitride (GaN) laser technology and its growing role in quantum sensing, computing, and defense applications. Winwood explained that gallium nitride is a compound semiconductor that can conduct electrons significantly faster than traditional silicon. BluGlass is one of a few companies globally producing visible lasers using GaN, a technology that is crucial in precision applications such as post-GPS navigation and quantum computing. “BluGlass is leading the market in the precision applications and these precision applications are the ones that are growing more rapidly,” Winwood said. The company works with large clients such as the US Department of Defense and major semiconductor players like General Electric and Coherent. BluGlass has recently secured contracts worth USD 6 million and aims to build long-term, revenue-generating relationships through projects that can lead to multi-decade manufacturing deals. In addition to commercial traction, BluGlass has strengthened its leadership with the appointment of industry veterans, including Nobel Laureate Shuji Nakamura. The company also recently demonstrated a world-record performance combining power and precision for quantum use cases. #BluGlass #QuantumComputing #GaNtechnology #GalliumNitride #Semiconductors #QuantumSensing #DefenseTech #LaserTechnology #InvestorUpdates #TechInnovation

Proactive - Interviews for investors

Saunders expands defense & fuel infrastructure work

Saunders International Ltd Managing Director and CEO Mark Benson talked with Proactive at the AIM's Small and Midcap Conference about the company’s strong momentum, recent project wins and the strategic expansion into defense and infrastructure sectors. Benson highlighted Saunders’ transformation from a tank constructor to a multi-disciplined, end-to-end engineering and construction provider. “We’ve diversified and become a multi-disciplined business… Now some of the projects we can do end-to-end,” he said, referencing the company’s work on the **Western Sydney Airport**, where it completed all elements from fuel tank construction to apron pipeline delivery. He also noted Saunders’ acquisition strategy as a driver of growth, enabling delivery of complex infrastructure through internal capabilities. Notable acquisitions include piping, civil infrastructure, and automation companies, helping the company expand its offering and grow organically and through M&A. Benson discussed the company’s extensive work in the defense sector, including the **Larrakeyah Defense Precinct** in Darwin, where Saunders handled the complete marine diesel infrastructure — from delivery to ship fueling — a capability he said sets the company apart. “Typically it’s done through 3 to 6 contractors. Now we can do that end to end.” The company now sees a $2.3 billion pipeline of directly addressable opportunities, with up to $4.8 billion in total defense-related fuel infrastructure upgrades anticipated across the next decade. Saunders is actively tendering for $580 million of that. Benson said Saunders’ unique value in defense projects includes not just technical delivery but risk reduction for government clients. “In defense, it’s not all about price. Sometimes price evaluation is only 30%. It’s about de-risking the project for the Commonwealth.” Visit Proactive’s YouTube channel for more company interviews, and don’t forget to like the video, subscribe to the channel, and turn on notific

Proactive - Interviews for investors

atai CEO outlines strategic focus for 2025 including four major data readouts

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) CEO and co-founder Dr Srinivas Rao talked with Proactive about the company's upcoming clinical milestones and strategic focus in 2025. Rao outlined four major clinical readouts across atai’s pipeline of short-duration psychedelics, including updates on VLS-01, BPL-003, RL-007 and EMP-01. The company has dosed its first patient in the VLS-01 trial for treatment-resistant depression, a study that includes an innovative two-dose approach. Rao noted, “This will be the first data set that's going to come out that really addresses the question of what is the incremental benefit of a re-dose?” The trial is expected to read out in Q1 of next year. The BPL-003 trial has completed enrolment and is expected to report results mid-year, alongside RL-007, which targets cognitive impairment associated with schizophrenia. EMP-01, which focuses on social anxiety disorder, is also underway with data expected around the same time as VLS-01. Rao also highlighted that atai recently raised additional capital, extending its funding runway into 2027. The company is focused on short-duration psychedelics with easy-to-administer formulations, such as VLS-01's oral strip delivery system. For more interviews and updates from innovative biotech companies, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe to the channel, and turn on notifications for future content. #ataiLifeSciences #Biotech #Pharmaceuticals #PsychedelicTherapy #ClinicalTrials #MentalHealth #TreatmentResistantDepression #Schizophrenia #SocialAnxietyDisorder #VLS01 #RL007 #BPL003 #EMP01 #ProactiveInvestors

Proactive - Interviews for investors

Acusensus talks global expansion and growth drivers

Acusensus Ltd Managing Director talked with Proactive at AIM's Small and Midcap Conference about the company’s progress in road safety technology, its global expansion, and the upcoming launch of a new product line aimed at road worker protection. Alex Jannink, Managing Director and Co-founder of Acusensus, explained how the company pioneered enforcement cameras targeting behaviours like mobile phone use and seatbelt compliance. “We supply these automated enforcement cameras...and we receive a fixed monthly fee essentially for those services,” he said, outlining the company's outsourced business model under long-term government contracts. While 93% of revenues currently come from Australia, Jannink confirmed growth is underway internationally, with active customers in the United States and United Kingdom. Acusensus has also secured a nationwide speed enforcement contract in New Zealand, expected to contribute significantly from the next financial year. Jannink highlighted the broader social mission behind the business: “The whole goal of the company is to change behaviours and to save lives.” He pointed to strong behavioural impacts from previous deployments, including a six-fold drop in mobile phone use and a 21% reduction in road fatalities in New South Wales. A new road worker safety product line is also in development and, according to Jannink, “can be as large as the enforcement business.” #Acusensus #RoadSafety #AItechnology #TrafficEnforcement #DriverSafety #ASXStocks #GovernmentContracts #InfrastructureSafety #SmartCameras #RoadWorkerProtection #AutonomousTech #InvestSmart #PublicSafetyTech

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free